Toxic metals and antioxidants: Part II. The role of antioxidants in arsenic and cadmium toxicity.

Exposure to toxic metals has become an increasingly recognized source of illness worldwide. Both cadmium and arsenic are ubiquitous in the environment, and exposure through food and water as well as occupational sources can contribute to a well-defined spectrum of disease. The symptom picture of arsenic toxicity is characterized by dermal lesions, anemia, and an increased risk for cardiovascular disease, diabetes, and liver damage. Cadmium has a significant effect on renal function, and as a result alters bone metabolism, leading to osteoporosis and osteomalacia. Cadmium-induced genotoxicity also increases risk for several cancers. The mechanisms of arsenic- and cadmium-induced damage include the production of free radicals that alter mitochondrial activity and genetic information. The metabolism and excretion of these heavy metals depend on the presence of antioxidants and thiols that aid arsenic methylation and both arsenic and cadmium metallothionein-binding. S-adenosylmethionine, lipoic acid, glutathione, selenium, zinc, N-acetylcysteine (NAC), methionine, cysteine, alpha-tocopherol, and ascorbic acid have specific roles in the mitigation of heavy metal toxicity. Several antioxidants including NAC, zinc, methionine, and cysteine, when used in conjunction with standard chelating agents, can improve the mobilization and excretion of arsenic and cadmium.

[1]  M. Tohkin,et al.  Mechanism of antihepatotoxic activity of glycyrrhizin. I: Effect on free radical generation and lipid peroxidation. , 1984, Planta medica.

[2]  A. D. Shamel,et al.  NATIONAL ACADEMY OF SCIENCES. , Science.

[3]  M. Luster,et al.  Toxic metals stimulate inflammatory cytokines in hepatocytes through oxidative stress mechanisms. , 1998, Toxicology and applied pharmacology.

[4]  Moiz Mumtaz,et al.  Evaluation of Indoor Air Sampling Near Philip Services Corporation, Seattle, Health Consultation , 1992 .

[5]  J. Staessen,et al.  Public health implications of environmental exposure to cadmium and lead: an overview of epidemiological studies in Belgium. Working Groups. , 1996, Journal of cardiovascular risk.

[6]  C. Chen,et al.  Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. , 1989, American journal of epidemiology.

[7]  S. Flora,et al.  Influence of methionine and zinc supplementation during chelation of lead in rats. , 1994, Journal of trace elements and electrolytes in health and disease.

[8]  Y. Liu,et al.  Metallothionein plays less of a protective role in cadmium-metallothionein-induced nephrotoxicity than in cadmium chloride-induced hepatotoxicity. , 1996, The Journal of pharmacology and experimental therapeutics.

[9]  L Järup,et al.  Health effects of cadmium exposure--a review of the literature and a risk estimate. , 1998, Scandinavian journal of work, environment & health.

[10]  R. Reiter,et al.  Induction of lipid peroxidation in hamster organs by the carcinogen cadmium: amelioration by melatonin , 2004, Cell Biology and Toxicology.

[11]  A. Smith,et al.  Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. , 1996, Environmental health perspectives.

[12]  P. Coyle,et al.  Metallothionein: the multipurpose protein , 2002, Cellular and Molecular Life Sciences CMLS.

[13]  B. Fowler General subcellular effects of lead, mercury, cadmium, and arsenic. , 1978, Environmental health perspectives.

[14]  P. Varalakshmi,et al.  Relationship between glutathione and DL alpha-lipoic acid against cadmium-induced hepatotoxicity. , 1996, Japanese journal of medical science & biology.

[15]  B Lind,et al.  Cadmium in kidney cortex, liver, and pancreas from Swedish autopsies. Estimation of biological half time in kidney cortex, considering calorie intake and smoking habits. , 1976, Archives of environmental health.

[16]  K. Tsuchiya Factors influencing metabolism and toxicity of metals: a consensus report. , 1978, Environmental health perspectives.

[17]  K. Hurlbut,et al.  Mobilization of heavy metals by newer, therapeutically useful chelating agents. , 1995, Toxicology.

[18]  G. Brewer,et al.  Recognition, diagnosis, and management of Wilson's disease. , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[19]  B. D. Beck,et al.  The enigma of arsenic carcinogenesis: role of metabolism. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[20]  C. J. Chen,et al.  Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. , 1990, Cancer research.

[21]  Jie Liu,et al.  The effects of 10 triterpenoid compounds on experimental liver injury in mice. , 1994, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[22]  B. Fowler,et al.  Factors influencing metabolism and toxicity of metals: a consensus report , 1978 .

[23]  M. Rahman,et al.  Hypertension and arsenic exposure in Bangladesh. , 1999, Hypertension.

[24]  R. Palmiter,et al.  Metallothionein-I-transgenic mice are not protected from acute cadmium-metallothionein-induced nephrotoxicity. , 1996, Toxicology and applied pharmacology.

[25]  O. Andersen,et al.  Effects of Simultaneous Low-level Dietary Supplementation with Inorganic and Organic Selenium on Whole-body, Blood, and Organ Levels of Toxic Metals in Mice , 1994 .

[26]  N. Sugawara,et al.  Selenium protection against testicular lipid peroxidation from cadmium. , 1984, Journal of applied biochemistry.

[27]  R. Goyer,et al.  Role of metallothionein in human placenta and rats exposed to cadmium. , 1992, IARC scientific publications.

[28]  S. Toyokuni,et al.  The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2'-deoxyguanosine in arsenic-related Bowen's disease. , 1999, The Journal of investigative dermatology.

[29]  Z. Gregus,et al.  Effect of arsenicals on biliary excretion of endogenous glutathione and xenobiotics with glutathione-dependent hepatobiliary transport. , 1991, Biochemical pharmacology.

[30]  A. Pizent,et al.  Semen quality and reproductive endocrine function in relation to biomarkers of lead, cadmium, zinc, and copper in men. , 1999, Environmental health perspectives.

[31]  Geoffrey A. Cordell,et al.  Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis , 1995, Nature Medicine.

[32]  L. Friberg,et al.  Airborne arsenic and urinary excretion of metabolites of inorganic arsenic among smelter workers , 1986, International archives of occupational and environmental health.

[33]  H. Hu,et al.  Exposure to metals. , 2000, Primary care.

[34]  Howard Hu,et al.  Cadmium exposure and nephropathy in a 28-year-old female metals worker. , 2002, Environmental health perspectives.

[35]  H. Aposhian,et al.  Arsenite methylation by methylvitamin B12 and glutathione does not require an enzyme. , 1999, Toxicology and applied pharmacology.

[36]  D. R. Lewis,et al.  Drinking water arsenic in Utah: A cohort mortality study. , 1999, Environmental health perspectives.

[37]  R. Lilis,et al.  Acute arsenic intoxication from environmental arsenic exposure. , 1989, Archives of environmental health.

[38]  Jie Liu,et al.  Metallothionein: an intracellular protein to protect against cadmium toxicity. , 1999, Annual review of pharmacology and toxicology.

[39]  L. Teppo,et al.  Health effects of cadmium exposure - a review of the literature and a risk estimate , 1998 .

[40]  N. Aykin-Burns,et al.  Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. , 2001, Current topics in medicinal chemistry.

[41]  E. Casalino,et al.  Molecular inhibitory mechanisms of antioxidant enzymes in rat liver and kidney by cadmium. , 2002, Toxicology.

[42]  N. Miura,et al.  Protective effects of triterpene compounds against the cytotoxicity of cadmium in HepG2 cells. , 1999, Molecular pharmacology.

[43]  C. Hopenhayn-Rich,et al.  Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water. , 2002, Environmental health perspectives.

[44]  D. Bagchi,et al.  Induction of oxidative stress by chronic administration of sodium dichromate [chromium VI] and cadmium chloride [cadmium II] to rats. , 1997, Free radical biology & medicine.

[45]  K Nogawa,et al.  Mechanism for bone disease found in inhabitants environmentally exposed to cadmium: decreased serum 1α, 25-dihydroxyvitamin D level , 1987, International archives of occupational and environmental health.

[46]  Cherian Mg,et al.  Role of metallothionein in human placenta and rats exposed to cadmium. , 1992 .

[47]  M. Vahter,et al.  Low-level arsenic excretion in breast milk of native Andean women exposed to high levels of arsenic in the drinking water , 1998, International archives of occupational and environmental health.

[48]  M. Deters,et al.  Influence of glycine on the damage induced in isolated perfused rat liver by five hepatotoxic agents. , 1998, Toxicology.

[49]  A. Flegal,et al.  Skeletal concentrations of lead, cadmium, zinc, and silver in ancient North American Pecos Indians. , 1991, Environmental health perspectives.

[50]  T. Tai,et al.  Lipid Profile and Peripheral Vascular Disease in Arseniasis-Hyperendemic Villages in Taiwan , 1997, Angiology.

[51]  M. Berglund,et al.  Intestinal absorption of dietary cadmium in women depends on body iron stores and fiber intake. , 1994, Environmental health perspectives.

[52]  Z. Shaikh,et al.  Oxidative stress as a mechanism of chronic cadmium-induced hepatotoxicity and renal toxicity and protection by antioxidants. , 1999, Toxicology and applied pharmacology.

[53]  Q. Fernaǹdo,et al.  Human studies with the chelating agents, DMPS and DMSA. , 1992, Journal of toxicology. Clinical toxicology.

[54]  Y. Hsueh,et al.  Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan. , 2001, Environmental health perspectives.

[55]  K. Mizukoshi,et al.  Mortality of inhabitants in an area polluted by cadmium: 15 year follow up. , 1995, Occupational and environmental medicine.

[56]  J. Staessen,et al.  Renal effects of cadmium body burden of the general population , 1990, The Lancet.

[57]  H. Adami,et al.  International renal‐cell cancer study. IV. Occupation , 1995, International journal of cancer.

[58]  Y. Awasthi,et al.  Effect of chronic cadmium exposure on glutathione S-transferase and glutathione peroxidase activities in rhesus monkey: the role of selenium. , 1993, Toxicology.

[59]  K. Min,et al.  Paradigm shift in zinc: metal pathology. , 2002, The Tohoku journal of experimental medicine.

[60]  M. Lai,et al.  Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. , 2000, Environmental health perspectives.

[61]  M. Waalkes,et al.  Induction of apoptosis in cells by cadmium: quantitative negative correlation between basal or induced metallothionein concentration and apoptotic rate. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[62]  H. Kay Environmental Health Criteria , 1980 .

[63]  S. Prasad,et al.  Influence of methionine administration during chelation of cadmium by CaNa(3)DTPA and DMPS in the rat. , 1997, Environmental Toxicology and Pharmacology.

[64]  S. Flora ARSENIC‐INDUCED OXIDATIVE STRESS AND ITS REVERSIBILITY FOLLOWING COMBINED ADMINISTRATION OF N‐ACETYLCYSTEINE AND MESO 2,3–DIMERCAPTOSUCCINIC ACID IN RATS , 1999, Clinical and experimental pharmacology & physiology.

[65]  T. Kjellström,et al.  Cadmium exposure from smoking cigarettes: variations with time and country where purchased. , 1983, Environmental research.

[66]  S. Das Gupta,et al.  Apoptosis and necrosis in developing brain cells due to arsenic toxicity and protection with antioxidants. , 2002, Toxicology letters.

[67]  O. Levander Metabolic interrelationships between arsenic and selenium , 1977, Environmental health perspectives.

[68]  C. Klaassen,et al.  Metallothionein as a trap for reactive organic intermediates. , 1981, Advances in experimental medicine and biology.

[69]  Surendra Singh,et al.  Chelation in metal intoxication: influence of cysteine or N‐acetyl cysteine on the efficacy of 2,3‐dimercaptopropane‐1‐sulphonate in the treatment of cadmium toxicity , 2002, Journal of applied toxicology : JAT.

[70]  M. Vahter,et al.  Exposure to inorganic arsenic metabolites during early human development. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[71]  T Sorahan,et al.  Lung cancer mortality in a cohort of workers employed at a cadmium recovery plant in the United States: an analysis with detailed job histories. , 1997, Occupational and environmental medicine.

[72]  W. Wąsowicz,et al.  Blood concentration of essential trace elements and heavy metals in workers exposed to lead and cadmium. , 2001, International journal of occupational medicine and environmental health.

[73]  E. Wildfang,et al.  How is Inorganic Arsenic Detoxified , 1999 .

[74]  S. Chattopadhyay,et al.  Effect of high arsenic content in drinking water on rat brain. , 1999, Indian journal of biochemistry & biophysics.

[75]  M. Bansal,et al.  Effect of Selenium Supplementation on the Glutathione Redox System in the Kidney of Mice after Chronic Cadmium Exposures , 1997, Journal of applied toxicology : JAT.

[76]  A. Smith,et al.  Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[77]  R. Calderon,et al.  Arsenic : exposure and health effects , 1997 .

[78]  G. Nordberg,et al.  Cadmium in the Human Environment: Toxicity and Carcinogenicity , 1992 .

[79]  E. Kenyon,et al.  Influence of dietary selenium on the disposition of arsenate in the female B6C3F1 mouse. , 1997, Journal of toxicology and environmental health.

[80]  E. Marafante,et al.  Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit. , 1987, Toxicology letters.

[81]  M. Cogswell,et al.  Dietary intake does not account for differences in low iron stores among Mexican American and non-Hispanic white women: Third National Health and Nutrition Examination Survey, 1988-1994. , 2002, The Journal of nutrition.

[82]  M. Fox Nutritional Factors that May Influence Bioavailability of Cadmium , 1988 .

[83]  M. Sjöström,et al.  Influence of zinc and copper administration on metal disposition in rats with cadmium-metallothionein-induced nephrotoxicity. , 1994, Toxicology and applied pharmacology.

[84]  S. Nakagawa,et al.  Sterol and triterpene derivatives from plants inhibit the effects of a tumor promoter, and sitosterol and betulinic acid inhibit tumor formation in mouse skin two-stage carcinogenesis. , 1991, Oncology.

[85]  S. Choudhuri,et al.  Oleanolic acid protects against cadmium hepatotoxicity by inducing metallothionein. , 1993, The Journal of pharmacology and experimental therapeutics.

[86]  L. Järup,et al.  Cadmium and lead in blood in relation to low bone mineral density and tubular proteinuria. , 2002, Environmental health perspectives.

[87]  J. Staessen,et al.  Public Health Implications of Environmental Exposure to Cadmium and Lead: An Overview of Epidemiological Studies in Belgium , 1996 .

[88]  A. Leber,et al.  A mechanism for cadmium- and zinc-induced tolerance to cadmium toxicity: involvement of metallothionein. , 1976, Toxicology and applied pharmacology.

[89]  J. Nielsen,et al.  Effects of simultaneous low-level dietary supplementation with inorganic and organic selenium on whole-body, blood, and organ levels of toxic metals in mice. , 1994, Environmental health perspectives.

[90]  Y. Hsueh,et al.  Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure. , 1998, Atherosclerosis.

[91]  F. Mullick,et al.  Pathology related to chronic arsenic exposure. , 2002, Environmental health perspectives.

[92]  A. Pope,et al.  Environmental Medicine INTEGRATING A MISSING ELEMENT INTO MEDICAL EDUCATION , 2013, Nature Medicine.

[93]  H. Menzel,et al.  Studies on the efficacy of lipoate and dihydrolipoate in the alteration of cadmium2+ toxicity in isolated hepatocytes. , 1990, Biochimica et biophysica acta.

[94]  E. Larsen,et al.  Bioavailability and speciation of arsenic in carrots grown in contaminated soil. , 1998, The Analyst.

[95]  Paul J Thornalley,et al.  Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. , 1985, Biochimica et biophysica acta.

[96]  A H Smith,et al.  Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States. , 1994, Archives of environmental health.

[97]  R. Little,et al.  Complications of pregnancy in relation to maternal lipid peroxides, glutathione, and exposure to metals. , 1994, Reproductive toxicology.